President Trump’s drug discount initiative, TrumpRx, launched with high expectations, but the reality has not met the initial hype. Nearly a month after debuting, the platform offers limited availability of prescription drugs and lacks key usage data. Despite claims of lowest prices, many medications have more affordable generic options. TrumpRx Launch Overview TrumpRx was introduced ...

Hospital access to Mark Cuban Cost Plus Drugs and other alternative suppliers will be expanded through a new strategic partnership between Bluesight and GraphiteRx. This alliance, which brings marketplace data into CostCheck and ShortageCheck, will help hospitals reduce drug spend and strengthen resilience amid ongoing shortages, according to a Bluesight news release. Through the partnership, ...

Researchers tested different medical scenarios with the chatbot. In more than half of cases in which doctors would send patients to the ER, the chatbot said it was OK to delay care.

Despite the loss of federal subsidies that lowered costs for millions, California’s private health insurance marketplace held nearly steady this enrollment season. In all, 1.9 million Californians renewed their plan or selected one for the first time — a 2.7% drop compared to last year. A closer look, however, shows that Californians are making concessions ...

The Trump administration is proposing Obamacare plans that it says will lower health insurance premiums. But critics warn they would make care unaffordable.

Marketers are having a tougher time selling high-definition health plans together with health accounts, and they’re having a tougher time getting workers to focus on the health account offers. The percentage of U.S. adults with a combination of HDHP coverage and a health savings account or health reimbursement arrangement fell to 15% in 2025, according to new survey data ...